Drug intelligence / Profile preview

terbutaline sulphate

Development stage
Approved
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral, Subcutaneous, Intravenous, Intramuscular
01

Overview

Terbutaline sulphate is a small molecule pharmaceutical drug classified as a selective beta-2 adrenergic receptor agonist. It acts primarily by stimulating beta-2 adrenergic receptors in bronchial smooth muscle, leading to activation of adenylyl cyclase and increased intracellular cyclic AMP (cAMP). This cascade results in decreased intracellular calcium, relaxation of bronchial smooth muscle, and bronchodilation. Terbutaline sulphate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma, chronic bronchitis, emphysema, or other reversible obstructive airway diseases. It is available as oral tablets and injectable formulations. While it has been used off-label as a tocolytic agent to delay preterm labor, this use is not recommended due to serious maternal and fetal risks[1][5][6][9].

Brand names
BrethineBricanyl
Other names
terbutaline sulfateterbutaline
02

Targets

ADRB2 (β2)

Beyond the preview

Go deeper on terbutaline sulphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on terbutaline sulphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call